U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-KSB

(Mark  One)
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                               For the fiscal year ended March 31, 2007.


TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
                               For the transition period from _______ to _______

                         Commission file number: 0-30520


                        GLOBAL IMMUNE TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
                 (Name of Small Business Issuer in its Charter)


         Wyoming                                            98-05327255
------------------------                         -------------------------------
(State  of Incorporation)                       (IRS EmployerIdentification No.)


1111-207  West  Hastings  St.,  Vancouver, B.C. Canada               V6G 1H7
------------------------------------------------------          ----------------
(Address  of  principal  executive  offices)                       (Zip  Code)


Issuer's telephone number, (   604   )      351      -      9443
                           -----------  ------------   --------------


        Securities Registered Pursuant of Section 12(b) of the Act: None

          Securities Registered Pursuant of Section 12(g) of the Act:
                        Common Stock, Without Par Value

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act of 1934  during the  preceding  12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days.  Yes  [X]  No  [ ]

Check if there is no disclosure of delinquent  filers in response to Item 405 of
Regulation S-B in this form, and no disclosure will be contained, to the best of
registrant's   knowledge,   in  definitive   proxy  or  information   statements
incorporated  by  reference in Part III of this Form 10-KSB or any  amendment of
this  Form  10-KSB.  [ ]

Indicate by check mark whether the registrant is a shell company (as defined by
Rule 12b-2 of the Exchange Act). Yes X     No
                                    ---       ---

The  issuer  had  operating  revenues of $-0- for the year ended March 31, 2007.

As  of March 31, 2007, there were 16,195,645 shares of the issuer's common stock
outstanding.  The  aggregate  market  value of the shares of the issuer's voting
stock  held  by  non-affiliates  was $1,457,608 based the average of the bid and
asked  price  as  quoted on the OTC Electronic Bulletin Board on March 31, 2007.
The  sum excludes the  shares  held by  officers,  directors,  and  stockholders
whose  ownership exceeded 10% of the  outstanding  shares at March 31, 2007,  in
that such persons may be deemed affiliates of the Company. This determination of
affiliate  status  is  not  necessarily  a  conclusive  determination  for other
purposes.


<PAGE>
                        Global Immune Technologies, Inc.
                                   FORM 10-KSB
                                 March 31, 2007


                                                                            Page
PART I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .

ITEM 1.  Description of Business. . . . . . . . . . . . . . . . . . . . . . . .
ITEM 2.  Description of Properties  . . . . . . . . . . . . . . . . . . . . . .
ITEM 3.  Legal Proceedings  . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 4.  Submission of Matters to Vote of Security Holders  . . . . . . . . . .

PART II   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITEM 5.  Market for Common Equity, Related Stockholder Matters and Small  . . .
           Business Issuer Purchases of Equity Securities . . . . . . . . . . .
ITEM 6.  Management's Discussion and Analysis or Plan of Operation  . . . . . .
ITEM 7.  Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 8.  Changes In and Disagreements With Accounting and Financial . . . . . .
           Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 8A. Controls and Procedures  . . . . . . . . . . . . . . . . . . . . . . .
ITEM 8B. Other Information  . . . . . . . . . . . . . . . . . . . . . . . . . .

PART III. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITEM 9.  Directors, Executive Officers, Promoters, and Control  . . . . . . . .
           Persons: Compliance with Section 16(a) of the Exchange Act . . . . .
ITEM 10.  Executive Compensation. . . . . . . . . . . . . . . . . . . . . . . .
ITEM 11.  Security Ownership of Certain Beneficial Owners and Management and. .
            Related Stockholder Matters . . . . . . . . . . . . . . . . . . . .
ITEM 12.  Certain Relationships and Related Transactions. . . . . . . . . . . .
ITEM 13.  Exhibits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM 14.  Principal Accounting Fees and Services. . . . . . . . . . . . . . . .
SIGNATURES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
EXHIBIT INDEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .


<PAGE>
PART  I

ITEM  1. DESCRIPTION  OF  BUSINESS.

FORWARD-LOOKING  STATEMENT  NOTICE:

This annual  report on Form 10-KSB  contains  many  forward-looking  statements,
which  involve  risks  and   uncertainties,   such  as  our  plans,   objective,
expectations  and  intentions.  You can identify these  statements by our use of
words  such as "may,"  "expect,"  "believe,"  "anticipate,"  "intend,"  "could,"
"estimate,"  "continue,"  "plans," or other  similar  words or phrases.  Some of
these statements include discussions  regarding our future business strategy and
our ability to generate revenue,  income,  and cash flow. We wish to caution the
reader that all  forward-looking  statements  contained  in this Form 10-KSB are
only estimates and predictions.  Our actual results could differ materially from
those  anticipated as a result of risk facing us or actual events differing from
the  assumptions  underlying  such  forward-looking   statements.   Readers  are
cautioned  not  to  place  undue  reliance  on  any  forward-looking  statements
contained  in  this  Annual  Report  on  Form  10-KSB.  Readers  are


<PAGE>
cautioned  not  to place undue  reliance  on these  forward-looking  statements.
We  undertake  no  obligation  to  update  any  of  these factors or to publicly
announce  any change to our  forward-looking  statements  made  herein,  whether
as  a  result  of  new  information,  future  events, changes in expectations or
otherwise.

     (a)     Our  Corporate  History.
             -----------------------

The  Company  was  incorporated  on  September  18,  1985, under the laws of the
Province  of  British  Columbia  under the name of Canadian Comstock Exploration
Ltd.  with  an  authorized share capital of 20,000,000 shares without par value.

The  Company  changed  its name on June 7, 1995 to American Comstock Exploration
Ltd.  in  connection with a consolidation of its share capital on a one for four
basis.

The  Company  changed  its  name  again  on  February  4, 1998 to "International
Comstock  Exploration  Ltd."  in  connection  with  a consolidation of its share
capital  on  a  one  for  five  basis.

The  Company  changed  its  name again on October 2, 2001 to "Secureview Systems
Inc."  in connection with a consolidation of its share capital on a one for five
basis.  In  addition,  the  Company  increased  its  authorized share capital to
100,000,000  shares  without  par  value  on  October  2,  2001.

The Company changed its name again on May 2, 2005 to "Global Immune Technologies
Inc."  In  addition,  the  Company  increased its authorized share capital to an
unlimited  number  of  common  shares  without  par  value  on  March  23, 2005.

On  February  28,  2006, the Company changed its corporate domicile from British
Columbia,  Canada  to  the  State  of  Wyoming.

     (b)     Business History of  the  Issuer.
             ---------------------------------

From  its  incorporation in 1985 until 1999, the Company has been engaged in the
business  of exploration of natural resource properties. During 2004 the Company
disposed  of  its  final  interests in its natural resource properties. In early
1999 the Company initiated a search for other business opportunities culminating
in  May  1999  with  the  acquisition  of  the domain name ProSportsPool.com. In
January 2000, the Company entered into an agreement with Internet Sports Network
Inc.  to  develop  and  maintain  a number of internet based games and contests.
Internet Sports Network eventually developed "Fantasy Free for All" software and
back  end  support  for Nascar, Formula One, Cart series and Baseball and Hockey
contests  for  ProSportsPool.com.  The  Company  launched  the  ProSportsool.com
website  on  March  1, 2000 with Formula 1 and NASCAR contests "Fantasy Free for
All".  The  launch  of  the website was accompanied by a marketing campaign that
included  print,  billboard, and internet-banner advertising. In March 21, 2000,
the  Company  engaged  Iceberg  Media.com Inc. to provide three music channels -
1Groove.com,  2Kool4Radio.com  and  PrimeTicket.net  - for the ProSportsPool.com
website.  The ProSportsPool.com website added a fantasy baseball contest, and an
affiliation  with  Altavista.com  on  March  27, 2000. At the beginning of April
2000,  the  Company launched its internet based hockey contest and announced its
inaugural  contest  winners  in  its  auto-racing  contests.  The  Company  also
announced  it  has become an authorized member of the Cnet.com affiliate network
and formed similar affiliations with Chipshot.com, Wrenchead.com, Quokka.com and
America  Online.

To increase awareness of the ProSportspool.com website, the Company participated
at  the  G.I.  Joe  200 CART race in Portland, Oregon as well as the Toronto and
Vancouver Indy races by appearing at a booth at the races signing up contestants
and  offering  prizes  to  entrants.  On January 15, 2001, due to the closing of
Internet  Sports  Network  Inc.,  which  provided the technical architecture and
sports  data for the ProSportsPool.com's sports contests, the Company was forced
to  discontinue  its  sports-contest  site.

During  June 2001 and amended October, 2001 the Company entered into a letter of
intent  with  Argent  Resources  Ltd., On-Track Computer Training Ltd., On-Track
Computer International Ltd. and Lute Linux.com Corp. whereby Argent assigned its
right  to enter into a share exchange agreement with Lute who held the option to
enter  into a share exchange agreement with On-Track and On-Track International.
In  exchange  for  the assignment by Argent to the Company of the share exchange
agreement  entered  into  between  Lute and Argent, the Company issued 2,000,000
shares  and  paid  $50,000  to  Argent.

During  October  2001  the Company signed an agreement with Lute Linux.com Corp.
including  the


<PAGE>
exchange of Lute share purchase warrants for Company shares at a deemed value of
$0.10  US per share, as to Russ Rossi (100,000 shares), RRGS Creative Management
Corp.  (2,400,000  shares) and Quest Ventures Ltd. (175,000 shares). The Company
did  not  proceed  with similar share purchase agreements with On-Track Computer
Training Ltd. and On-Track Computer International Ltd. Lute focused its business
development on its "Fedcam," an inexpensive remote monitoring system that allows
subscribers  to  view  their target locations via secure website. The Fedcam was
being  tested  by  the Canadian government's construction branch on its Osoyoos,
British  Columbia  border  crossing  site into the United States. However, as of
March  31, 2003, the Company ceased funding the Fedcam and the asset was written
down  to  a  nominal  amount.

In  June 2002 the Company entered into a letter of intent with Estwind Energy, a
private  power  generation  company incorporated in Estonia, whereby the Company
intended  to acquire all of the issued and outstanding shares of Estwind Energy.
However,  the Company decided against completing the share exchange agreement as
the  business  of  Estwind  Energy  was  deemed  to  not  be  profitable.

In  May  2003  the  Company entered into a letter of intent with P-CE Computers,
Inc.,  a  private  Nevada  corporation  engaged  in  the  business of developing
ergonomic  multimedia-computer  workstations.  The  Company  decided  against
completing  the  share  exchange  agreement  as due diligence indicated that the
business  of  P-CE  Computers,  Inc.  would  not  be  profitable.

In September 2003 the Company entered into a letter of intent with TNR Resources
Ltd.  ("TNR"), a public British Columbia, Canada, corporation, to purchase a 50%
working  interest  in  TNR's Las Carachas property in Argentina. The Company did
not  pursue  the  option.

In  February  2005  the  Company  entered an agreement to acquire the rights and
interests  in  a  drug,  Trioxolane. The Company did not pursue or complete this
acquisition.

Subsequently  to  March 31, 2005, the Company has agreed to purchase WSG Systems
Inc.,  ("WSG")  its' business and assets from Global Lottery Corporation for the
issuance  of  100,000,000  shares  of  common  stock.  The assets of WSG include
proprietary  technology,  software,  its  trade  names  and  trademarks as those
products  pertain to the worldwide lottery industry and/or worldwide pari-mutual
betting.  The  products  are designed to be used by all entities in the industry
for  conducting  lotteries  and  or  pari-mutual betting, including corporations
and/or  governmental agencies representing countries, provinces, states, etc. to
implement  and/or  to  improve their lottery and/or pari-mutual betting systems.

On  July 19, 2006, the Company entered into a securities exchange agreement with
MediPri Limited, Primemedical International, Ltd.("MedPri") and Medical Monitors
Limited  ("MML).  The  transaction was revised on May 17, 2007.  The transaction
was  rescinded  on  July  11,  2007.

     (c)     Current  Business  of  the  Issuer
             ----------------------------------

The  Company  may be referred to as a shell corporation.  Shell corporations are
defined  as  companies  with  no  or  nominal  assets  and  operations.  Private
companies  wishing  to become publicly trading may wish to merge with a shell (a
reverse  merger)  whereby  the  shareholders  of  the private Company become the
majority  of  the shareholders of the combined Company.  The private Company may
purchase for cash all or a portion of the common shares of the shell corporation
from  its  major stockholders.  Typically, the Board and officers of the private
Company  become the new Board and officers of the combined Company and often the
name  of  the  private  Company  becomes  the  name  of  the  combined  Company.

The  Company  has very limited capital, and it is unlikely that the Company will
be  able  to  take  advantage  of  more than one such business opportunity.  The
Company  intends  to seek opportunities demonstrating the potential of long-term
growth  as  opposed  to  short-term  earnings. However, at the present time, the
Company has not identified any business opportunity that it plans to pursue, nor
has  the  Company  reached  any  agreement  or definitive understanding with any
person  concerning  an  acquisition.

No  assurance  can  be  given  that the Company will be successful in finding or
acquiring  a  desirable  business  opportunity, given the limited funds that are
expected  to  be  available  for acquisitions.  Furthermore, no assurance can be
given  that  any  acquisition,  which  does  occur,  will  be  on terms that are
favorable  to  the  Company  or  its  current  stockholders.

The Company's search will be directed toward small and medium-sized enterprises,
which  have  a  desire  to  become  public  corporations.  In  addition  these
enterprises  may  wish  to  satisfy,  either currently or in the reasonably near
future,  the  minimum  tangible  asset  requirement  in  order  to


<PAGE>
qualify  shares  for  trading  on  NASDAQ or on an exchange such as the American
Stock  Exchange.  (See  Investigation  and Selection of Business Opportunities).
The Company anticipates that the business opportunities presented to it will (i)
either  be  in  the  process of formation, or be recently organized with limited
operating history or a history of losses attributable to under-capitalization or
other  factors;  (ii) experiencing financial or operating difficulties; (iii) be
in  need  of  funds  to develop new products or services or to expand into a new
market,  or  have  plans  for  rapid  expansion through acquisition of competing
businesses;  (iv)  or  other  similar  characteristics.  The  Company intends to
concentrate its acquisition efforts on properties or businesses that it believes
to  be  undervalued  or  that it believes may realize a substantial benefit from
being publicly owned.  Given the above factors, investors should expect that any
acquisition  candidate  may have little or no operating history, or a history of
losses  or  low  profitability.

The Company does not propose to restrict its search for investment opportunities
to  any  particular geographical area or industry, and may, therefore, engage in
essentially any business, to the extent of its limited resources.  This includes
industries  such  as  service,  finance,  natural resources, manufacturing, high
technology,  product  development,  medical,  communications  and  others.  The
Company's discretion in the selection of business opportunities is unrestricted,
subject  to  the  availability  of  such opportunities, economic conditions, and
other  factors.

In  connection  with  such  a merger or acquisition, it is highly likely that an
amount  of  stock  constituting control of the Company would either be issued by
the  Company  or  be  purchased  from  the current principal stockholders of the
Company  by  the acquiring entity or its affiliates.  If stock is purchased from
the  current  principal  stockholders,  the  transaction  is likely to result in
substantial  gains  to  the  current  principal  stockholders  relative to their
purchase  price for such stock.  In the Company's judgment, none of the officers
and  directors  would  thereby  become  an underwriter within the meaning of the
Section  2(11)  of  the  Securities  Act  of  1933,  as  amended  as long as the
transaction  is  a  private  transaction  rather  than  a public distribution of
securities.  The  sale  of  a  controlling  interest  by  certain  principal
shareholders of the Company would occur at a time when minority stockholders are
unable  to  sell  their  shares  because of the lack of a public market for such
shares.

Depending upon the nature of the transaction, the current officers and directors
of  the Company may resign their management and board positions with the Company
in  connection with a change of control or acquisition of a business opportunity
(See  Form  of  Acquisition,  below,  and  Risk  Factors,  The Company,  Lack of
Continuity  of  Management).  In  the event of such a resignation, the Company's
current  management  would  thereafter  have  no control over the conduct of the
Company's  business.

It  is  anticipated  that  business  opportunities  will  come  to the Company's
attention  from various sources, including its officers and directors, its other
stockholders,  professional  advisors  such  as  attorneys  and  accountants,
securities  broker-dealers,  venture  capitalists,  members  of  the  financial
community,  and others who may present unsolicited proposals. The Company has no
plan,  understandings,  agreements,  or commitments with any individual for such
person  to  act  as  a  finder  of  opportunities  for  the  Company.

The  Company  does  not  foresee that it will enter into a merger or acquisition
transaction with any business with which its officers or directors are currently
affiliated.  Should  the  Company  determine  in  the  future,  contrary  to the
forgoing expectations, that a transaction with an affiliate would be in the best
interests  of  the  Company  and  its  stockholders, the Company is, in general,
permitted  by  Wyoming law to enter into a transaction if: The material facts as
to  the  relationship  or  interest  of  the affiliate and as to the contract or
transaction  are disclosed or are known to the Board of Directors, and the Board
in  good  faith  authorizes, approves or ratifies the contract or transaction by
the  affirmative  vote of a majority of the disinterested directors, even though
the disinterested directors constitute less than a quorum; or the material facts
as  to  the  relationship or interest of the affiliate and as to the contract or
transaction  are  disclosed  or  are  known to the stockholders entitled to vote
thereon, and the contract or transaction is specifically authorized, approved or
ratified  in  good  faith  by  vote  of  the  stockholders;  or  the contract or
transaction  is fair as to the Company as of the time it is authorized, approved
or  ratified,  by  the  Board  of  Directors  or  the  stockholders.

          (1)     Investigation  and  Selection  of  Business  Opportunities

To  a large extent, a decision to participate in a specific business opportunity
may  be  made  upon  management's analysis of the quality of the other Company's
management  and  personnel,  the  anticipated  acceptability  of new products or
marketing  concepts,  the  merit  of  technological


<PAGE>
changes,  the  perceived  benefit  the  business  opportunity  will  derive from
becoming a publicly held entity, and numerous other factors which are difficult,
if not impossible, to analyze through the application of any objective criteria.
In  many  instances,  it  is  anticipated  that  the  historical operations of a
specific business opportunity may not necessarily be indicative of the potential
for  the  future because of a variety of factors, including, but not limited to,
the  possible  need  to expand substantially, shift marketing approaches, change
product  emphasis, change or substantially augment management, raise capital and
the  like.

It  is  anticipated  that  the  Company  will not be able to diversify, but will
essentially be limited to the acquisition of one business opportunity because of
the  Company's  limited financing.  This lack of diversification will not permit
the  Company  to  offset  potential losses from one business opportunity against
profits  from  another, and should be considered an adverse factor affecting any
decision  to  purchase  the  Company's  securities.

Certain  types of business acquisition transactions may be completed without any
requirement  that  the  Company first submit the transaction to the stockholders
for their approval.  In the event the proposed transaction is structured in such
a  fashion  that  stockholder approval is not required, holders of the Company's
securities  (other  than  principal stockholders holding a controlling interest)
should  not  anticipate  that they will be provided with financial statements or
any other documentation prior to the completion of the transaction.  Other types
of  transactions  require  prior  approval  of  the  stockholders.

In the event a proposed business combination or business acquisition transaction
is  structured  in  such a fashion that prior stockholder approval is necessary,
the  Company  will  be  required  to  prepare  a  Proxy or Information Statement
describing  the  proposed  transaction, file it with the Securities and Exchange
Commission  for  review  and  approval,  and  mail  a  copy of it to all Company
stockholders  prior  to holding a stockholders meeting for purposes of voting on
the  proposal.  Minority  shareholders  that  do not vote in favor of a proposed
transaction  will  then have the right, in the event the transaction is approved
by the required number of stockholders, to exercise statutory dissenter's rights
and  elect  to  be  paid  the  fair  value  of  their  shares.

The  analysis  of  business  opportunities  will  be  undertaken by or under the
supervision  of  the  Company's  officers  and  directors,  none  of  whom  are
professional  business analysts (See Management).  Although there are no current
plans to do so, Company management might hire an outside consultant to assist in
the  investigation  and  selection  of  business  opportunities, and might pay a
finder's  fee.  Since Company management has no current plans to use any outside
consultants or advisors to assist in the investigation and selection of business
opportunities,  no  policies have been adopted regarding use of such consultants
or  advisors, the criteria to be used in selecting such consultants or advisors,
the  services  to  be provided, the term of service, or the total amount of fees
that  may be paid.  However, because of the limited resources of the Company, it
is likely that any such fee the Company agrees to pay would be paid in stock and
not  in  cash.

Otherwise,  in  analyzing  potential  business opportunities, Company management
anticipates  that  it  will consider, among other things, the following factors:

     -    Potential  for  growth  and  profitability  indicated  by  new
          technology,  anticipated  market  expansion,  or  new  products;

     -    The Company's  perception  of  how  any  particular  business
          opportunity  will  be  received by the investment community and by the
          Company's  stockholders;

     -    Whether,  following  the  business  combination,  the  financial
          condition  of  the  business  opportunity  would  be,  or would have a
          significant prospect in the foreseeable future of becoming, sufficient
          to  enable  the securities of the Company to qualify for listing on an
          exchange  or on a national automated securities quotation system, such
          as NASDAQ, so as to permit the trading of such securities to be exempt
          from  the  requirements  of  Rule  15g-9 adopted by the Securities and
          Exchange Commission (See Risk Factors The Company Regulations of Penny
          Stocks).

     -    Capital  requirements  and  anticipated  availability  of  required
          funds,  to  be provided by the Company or from operations, through the
          sale  of  additional  securities,  through  joint  ventures or similar
          arrangements,  or  from  other  sources;

     -    The  extent  to  which  the  business  opportunity  can  be  advanced;


<PAGE>
     -    Competitive  position  as  compared  to  other  companies  of  similar
          size  and experience within the industry segment as well as within the
          industry  as  a  whole;

     -    Strength  and  diversity  of  existing  management  or  management
          prospects  that  are  scheduled  for  recruitment;

     -    The cost  of  participation  by  the  Company  as  compared  to  the
          perceived  tangible  and  intangible  values  and  potential;  and

     -    The accessibility  of  required  management  expertise,  personnel,
          raw  materials,  services, professional assistance, and other required
          items.

No  one of the factors described above will be controlling in the selection of a
business  opportunity,  and  management  will  attempt  to  analyze  all factors
appropriate  to  each opportunity and make a determination based upon reasonable
investigative  measures  and  available  data.  Potentially  available  business
opportunities  may  occur  in many different industries and at various stages of
development,  all  of  which will make the task of comparative investigation and
analysis  of  such  business  opportunities  extremely  difficult  and  complex.
Potential  investors  must  recognize  that,  because  of  the Company's limited
capital  available  for  investigation  and  management's  limited experience in
business  analysis,  the Company may not discover or adequately evaluate adverse
facts  about  the  opportunity  to  be  acquired.

The  Company  is  unable  to  predict  when  it  may  participate  in a business
opportunity.  It  expects,  however, that the analysis of specific proposals and
the  selection  of  a  business  opportunity  may  take  several months or more.

Prior to making a decision to participate in a business opportunity, the Company
will  generally request that it be provided with written materials regarding the
business  opportunity  containing  as  much  relevant  information  as possible,
including, but not limited to, such items as a description of products, services
and  Company  history;  management  resumes;  financial  information;  available
projections,  with related assumptions upon which they are based; an explanation
of  proprietary products and services; evidence of existing patents, trademarks,
or  service marks, or rights thereto; present and proposed forms of compensation
to  management;  a  description  of  transactions  between  such Company and its
affiliates  during  the  relevant periods; a description of present and required
facilities;,  an  analysis of risks and competitive conditions; a financial plan
of  operation  and estimated capital requirements; audited financial statements,
or  if  they  are  not  available, unaudited financial statements, together with
reasonable  assurance  that  audited  financial  statements  would be able to be
produced  within  a  reasonable  period  of time not to exceed 60 days following
completion  of  a  merger  or  acquisition  transaction;  and  the  like.

As  part  of  the  Company's investigation, the Company's executive officers and
directors  may  meet personally with management and key personnel, may visit and
inspect  material  facilities,  obtain  independent  analysis or verification of
certain  information provided, check references of management and key personnel,
and take other reasonable investigative measures, to the extent of the Company's
limited  financial  resources  and  management  expertise.

It  is possible that the range of business opportunities that might be available
for  consideration  by  the Company could be limited by the impact of Securities
and Exchange Commission regulations regarding purchase and sale of penny stocks.
The regulations would affect, and possibly impair, any market that might develop
in  the  Company's  securities  until  such  time as they qualify for listing on
NASDAQ  or on an exchange which would make them exempt from applicability of the
penny  stock  regulations.  (See  Risk  Factors  Regulation  of  Penny  Stocks)

Company  management  believes  that  various  types  of  potential  merger  or
acquisition  candidates might find a business combination with the Company to be
attractive.  These  include  acquisition  candidates desiring to create a public
market  for their shares in order to enhance liquidity for current stockholders,
acquisition  candidates  which  have long-term plans for raising capital through
public  sale  of  securities  and believe that the possible prior existence of a
public  market  for  their  securities  would  be  beneficial,  and  acquisition
candidates  which  plan  to  acquire  additional  assets  through  issuance  of
securities rather than for cash, and believe that the possibility of development
of  a  public market for their securities will be of assistance in that process.
Acquisition  candidates,  which  have a need for an immediate cash infusion, are
not  likely  to  find a potential business combination with the Company to be an
attractive  alternative.


<PAGE>
          (2)     Form  of  Acquisition

It is impossible to predict the manner in which the Company may participate in a
business  opportunity.  Specific business opportunities will be reviewed as well
as  the  respective  needs  and  desires of the Company and the promoters of the
opportunity  and,  upon  the  basis  of  the review and the relative negotiating
strength of the Company and such promoters, the legal structure or method deemed
by  management to be suitable will be selected.  Such structure may include, but
is not limited to leases, purchase and sale agreements, licenses, joint ventures
and  other contractual arrangements.  The Company may act directly or indirectly
through an interest in a partnership, corporation or other form of organization.
Implementing  such  structure  may  require  the  merger,  consolidation  or
reorganization  of  the  Company  with  other  corporations or forms of business
organization.  In  addition,  the  present  management  and  stockholders of the
Company  most  likely will not have control of a majority of the voting stock of
the Company following a merger or reorganization transaction.  As part of such a
transaction,  the  Company's existing directors may resign and new directors may
be  appointed  without  any  vote  by  stockholders.

It  is  likely  that  the  Company  will acquire its participation in a business
opportunity  through  the  issuance  of  Common Stock or other securities of the
Company.  Although  the  terms  of  any such transaction cannot be predicted, it
should  be  noted  that  in  certain  circumstances the criteria for determining
whether or not an acquisition is a so-called B tax free reorganization under the
Internal  Revenue  Code  of  1986  as  amended, depends upon the issuance to the
stockholders  of  the  acquired  Company of a controlling interest (i.e., 80% or
more)  of  the  common  stock of the combined entities immediately following the
reorganization.  If  a  transaction  were  structured to take advantage of these
provisions  rather  than other a tax free provisions provided under the Internal
Revenue  Code,  the Company's current stockholders would retain in the aggregate
20%  or  less  of the total issued and outstanding shares.  This could result in
substantial  additional dilution in the equity of those who were stockholders of
the  Company  prior  to  such  reorganization.  Any  such issuance of additional
shares  might  also  be  done  simultaneously  with a sale or transfer of shares
representing  a  controlling  interest  in  the Company by the current officers,
directors  and  principal  stockholders.

It  is anticipated that any new securities issued in any reorganization would be
issued  in  reliance  upon  one  or  more  exemptions  from  registration  under
applicable  federal and state securities laws to the extent that such exemptions
are  available.  In  some circumstances, however, as a negotiated element of the
transaction,  the  Company  may  agree to register such securities either at the
time  the  transaction  is  consummated or under certain conditions at specified
times  thereafter.  The  issuance of substantial additional securities and their
potential  sale  into  any  trading  market  that might develop in the Company's
securities  may  have  a  depressive  effect  upon  such  market.

The  Company  will  participate  in  a  business  opportunity  only  after  the
negotiation  and  execution  of a written agreement.  Although the terms of such
agreement  cannot  be  predicted,  generally  such  an  agreement  would require
specific  representations  and warranties by all of the parties thereto, specify
certain  events of default, detail the terms of closing and the conditions which
must  be satisfied by each of the parties thereto prior to such closing, outline
the manner of bearing costs if the transaction is not closed, set forth remedies
upon  default,  and  include  miscellaneous  other  terms.

As  a  general  matter,  the  Company  anticipates that it, and/or its principal
stockholders  will enter into a letter of intent with the management, principals
or  owners  of  a  prospective  business  opportunity prior to signing a binding
agreement.  Such  a  letter  of  intent will set forth the terms of the proposed
acquisition  but will not bind any of the parties to consummate the transaction.
Execution  of  a letter of intent will by no means indicate that consummation of
an acquisition is probable.  Neither the Company nor any of the other parties to
the  letter  of  intent  will  be bound to consummate the acquisition unless and
until  a definitive agreement is executed.  Even after a definitive agreement is
executed,  it  is  possible that the acquisition would not be consummated should
any  party elect to exercise any right provided in the agreement to terminate it
on  specific  grounds.

It  is anticipated that the investigation of specific business opportunities and
the  negotiation,  drafting  and  execution  of  relevant agreements, disclosure
documents  and  other  instruments  will require substantial management time and
attention  and  substantial  costs  for accountants, attorneys and others.  If a
decision  is  made  not  to  participate in a specific business opportunity, the
costs incurred in the related investigation would not be recoverable.  Moreover,
because many providers of goods and services require compensation at the time or
soon  after the goods and services are provided, the inability of the Company to
pay  until  an  indeterminate


<PAGE>
future  time  may  make  it  impossible  to  produce  goods  and  services.

          (3)     Investment  Company  Act  and  Other  Regulation

The  Company may participate in a business opportunity by purchasing, trading or
selling  the securities of such business.  The Company does not, however, intend
to  engage  primarily  in such activities.  Specifically, the Company intends to
conduct  its activities so as to avoid being classified as an investment Company
under  the Investment Company Act of 1940 (the Investment Act), and therefore to
avoid  application  of  the  costly  and  restrictive  registration  and  other
provisions  of  the  Investment Act, and the regulations promulgated thereunder.

The  Company's  plan  of  business may involve changes in its capital structure,
management,  control  and  business,  especially  if  it  consummates  the
reorganization  as  discussed  above.  Each  of  these areas is regulated by the
Investment Act, in order to protect purchasers of investment Company securities.
Since  the Company will not register as an investment Company, stockholders will
not  be  afforded  these  protections.

Employees
---------

As  of datelstransMonth3Day31Year2007March 31, 2007 the Company had no full-time
employees.  Donald  Perks is the Company's sole officer and director.  Mr. Perks
works  on  a  part-time  basis.

RISK  FACTORS

THERE  ARE  SIGNIFICANT RISKS ASSOCIATED WITH AN INVESTMENT IN OUR COMMON STOCK.
BEFORE  MAKING  A DECISION CONCERNING THE PURCHASE OF OUR SECURITIES, YOU SHOULD
CAREFULLY  CONSIDER  THE  FOLLOWING FACTORS AND OTHER INFORMATION IN THIS ANNUAL
REPORT  WHEN  YOU  EVALUATE  OUR  BUSINESS.

BUSINESS  RISKS

LACK  OF  BUSINESS  HISTORY  AND  PROFITABILITY  OF  OPERATIONS
The  Company  is not currently operating profitably and it should be anticipated
that  it  will operate at a loss at least until such time as a business prospect
is  identified and profitability is achieved, if profitability is, in fact, ever
achieved.  The  Company  has  never  earned  a  significant  profit.

DEPENDENCE  ON  KEY  MANAGEMENT
The  success  of  the operations and activities of the Company is dependent to a
significant  extent  on the efforts and abilities of its management. The loss of
services  of  any  of its Management could have a material adverse effect on the
Company.  The  Company  does  not  maintain  key  man  insurance  on  any of its
management.  The  Company  does not have any employment or labor agreements with
any  personnel  as  at  the  date  of  the  filing  of  this  Annual  Report.

CONFLICTS  OF INTEREST.  Certain conflicts of interest exist between the Company
and  its  officers  and  directors.  They have other business interests to which
they  currently  devote  attention, and are expected to continue to do so.  As a
result,  conflicts of interest may arise that can be resolved only through their
exercise of judgment in a manner which is consistent with their fiduciary duties
to  the  Company.

It  is  anticipated  that  the  Company's  principal  shareholders  may actively
negotiate  or  otherwise  consent  to  the purchase of a portion of their common
stock as a condition to, or in connection with, a proposed merger or acquisition
transaction.  In this process, the Company's principal shareholders may consider
their  own  personal  pecuniary  benefit  rather than the best interest of other
Company  shareholders.  Depending  upon  the  nature  of a proposed transaction,
Company  shareholders  other than the principal shareholders may not be afforded
the  opportunity  to  approve  or  consent  to  a  particular  transaction.

INVESTMENT  RISKS

OUR  ISSUANCE  OF ADDITIONAL SHARES MAY HAVE THE EFFECT OF DILUTING THE INTEREST
OF  SHAREHOLDERS;  OUR  COMMON STOCK SHAREHOLDERS DO NOT HAVE PREEMPTIVE RIGHTS.

Any  additional issuances of common stock by us from our authorized but unissued
shares  may  have  the  effect  of  diluting the percentage interest of existing
shareholders.  The securities issued to raise funds may have rights, preferences
or  privileges  that are senior to those of the holders of our other securities,
including  our  common  stock.  The  board  of  directors has the power to issue


<PAGE>
such  shares  without  shareholder approval. We fully intend to issue additional
common  shares  in  order  to  raise capital to fund our business operations and
growth  objectives.

WE  DO NOT ANTICIPATE PAYING DIVIDENDS TO COMMON STOCKHOLDERS IN THE FORESEEABLE
FUTURE,  WHICH  MAKES  INVESTMENT  IN  OUR  STOCK  SPECULATIVE  OR  RISKY.

We  have  not  paid  dividends  on our common stock and do not anticipate paying
dividends  on our common stock in the foreseeable future. The board of directors
has  sole  authority  to declare dividends payable to our stockholders. The fact
that we have not and do not plan to pay dividends indicates that we must use all
of  our  funds  generated  by  operations  for  reinvestment  in  our  business
activities.  Investors also must evaluate an investment in the Company solely on
the  basis  of  anticipated  capital  gains.

LIMITED  LIABILITY  OF  OUR  EXECUTIVE  OFFICERS  AND  DIRECTORS  MAY DISCOURAGE
SHAREHOLDERS  FROM  BRINGING  A  LAWSUIT  AGAINST  THEM.

Our Articles of Incorporation contain provisions that limit the liability of our
directors  for  monetary damages and provide for indemnification of officers and
directors.  These provisions may discourage shareholders from bringing a lawsuit
against officers and directors for breaches of fiduciary duty and may reduce the
likelihood  of  derivative litigation against officers and directors even though
such  action, if successful, might otherwise have benefited the shareholders. In
addition, a shareholder's investment in the Company may be adversely affected to
the extent that we pay costs of settlement and damage awards against officers or
directors pursuant to the indemnification provisions of the bylaw. The impact on
a shareholder's investment in terms of the cost of defending a lawsuit may deter
the  shareholder from bringing suit against any of our officers or directors. We
have  been  advised that the SEC takes the position that these article and bylaw
provisions  do not affect the liability of any director under applicable federal
and  state  securities  laws.

LIMITED  MARKET  DUE  TO  PENNY  STOCK

The Company's stock differs from many stocks, in that it is a "penny stock." The
Securities  and  Exchange  Commission  has adopted a number of rules to regulate
"penny  stocks."  These rules  include,  but are not limited to,  Rules  3a5l-l,
15g-1,  15g-2,  15g-3,  15g-4,  15g-5,  15g-6 and 15g-7 under the Securities and
Exchange Act of 1934, as amended.  Because our  securities  probably  constitute
"penny stock"  within the meaning of the rules,  the rules would apply to us and
our securities.  The rules may further affect the ability of owners of our stock
to sell their securities in any market that may develop for them. There may be a
limited   market  for  penny   stocks,   due  to  the   regulatory   burdens  on
broker-dealers.  The market among dealers may not be active.  Investors in penny
stock  often are  unable to sell  stock  back to the  dealer  that sold them the
stock. The mark-ups or commissions  charged by the broker-dealers may be greater
than any profit a seller may make.  Because of large dealer  spreads,  investors
may be unable to sell the stock immediately back to the dealer at the same price
the dealer sold the stock to the  investor.  In some  cases,  the stock may fall
quickly in value.  Investors  may be unable to reap any profit  from any sale of
the  stock,  if they  can sell it at all.  Stockholders  should  be aware  that,
according to the Securities and Exchange  Commission  Release No. 34- 29093, the
market for penny stocks has suffered in recent years from  patterns of fraud and
abuse.  These patterns include:  - Control of the market for the security by one
or a few broker-  dealers that are often  related to the  promoter or issuer;  -
Manipulation of prices through  prearranged  matching of purchases and sales and
false  and misleading  press releases; - "Boiler room" practices  involving high
pressure sales tactics and unrealistic price projections by inexperienced  sales
persons;  -  Excessive  and  undisclosed  bid-ask  differentials  and markups by
selling broker- dealers;  and - The wholesale  dumping of the same securities by
promoters and broker-  dealers after prices have been  manipulated  to a desired
level,  along with the  inevitable  collapse  of those  prices  with  consequent
investor losses. Furthermore, the "penny stock" designation may adversely affect
the  development  of any public market for the Company's  shares of common stock
or, if such a market develops, its continuation.  Broker-dealers are required to
personally  determine  whether an  investment  in "penny  stock" is suitable for
customers.  Penny  stocks  are  securities  (i) with a price of less  than  five
dollars per share; (ii) that are not traded on a "recognized" national exchange;
(iii)  whose  prices  are not quoted on the NASDAQ  automated  quotation  system
(NASDAQ-listed  stocks must still meet  requirement  (i)  above);  or (iv) of an
issuer with net tangible  assets less than $2,000,000 (if the issuer has been in
continuous  operation for at least three years) or $5,000,000  (if in continuous
operation for less than three years),  or with average  annual  revenues of less
than $6,000,000 for the last three years. Section 15(g) of the Exchange Act, and
Rule 15g-2 of the Commission require  broker-dealers  dealing in penny stocks to
provide


<PAGE>
potential  investors with a document disclosing the risks of penny stocks and to
obtain  a  manually  signed  and  dated  written  receipt of the document before
effecting any transaction in a penny stock for the investor's account. Potential
investors  in the  Company's  common  stock are  urged to  obtain  and read such
disclosure  carefully before  purchasing any shares that are deemed to be "penny
stock." Rule 15g-9 of the Commission requires broker- dealers in penny stocks to
approve the  account of any  investor  for  transactions  in such stocks  before
selling  any  penny  stock  to  that  investor.   This  procedure  requires  the
broker-dealer to (i) obtain from the investor information  concerning his or her
financial  situation,  investment  experience  and investment  objectives;  (ii)
reasonably  determine,  based on that  information,  that  transactions in penny
stocks are  suitable  for the  investor  and that the  investor  has  sufficient
knowledge and experience as to be reasonably  capable of evaluating the risks of
penny stock  transactions;  (iii) provide the investor with a written  statement
setting forth the basis on which the  broker-dealer  made the  determination  in
(ii) above;  and (iv) receive a signed and dated copy of such statement from the
investor,  confirming  that it  accurately  reflects  the  investor's  financial
situation,  investment  experience and investment  objectives.  Compliance  with
these requirements may make it more difficult for the Company's  stockholders to
resell  their  shares  to  third  parties  or  to  otherwise  dispose  of  them.

Shareholders  should  be  aware  that,  according  to  Securities  and  Exchange
Commission  Release  No.  34-29093,  the market for penny stocks has suffered in
recent  years  form  patterns  of  fraud  and  abuse.  Such patterns include (i)
control  of  the market for the security by one or a few broker-dealers that are
often  related  to  the promoter or issuer;  (ii) manipulation of prices through
prearranged  matching  of  purchases  and  sales  and false and misleading press
releases;  (iii) boiler room practices involving high-pressure sales tactics and
unrealistic  price  projections  by inexperienced sales persons;  (iv) excessive
and  undisclosed bid-ask differential and markups by selling broker-dealers; and
(v) the wholesale dumping of the same securities by promoters and broker dealers
after  prices have been manipulated to a desired level, along with the resulting
inevitable  collapse  of  those prices and with consequent investor losses.  The
Company's  management  is aware of the abuses that have occurred historically in
the  penny  stock  market.  Although  the  Company  does  not  expect to be in a
position  to  dictate  the  behavior  of  the  market  or  of broker dealers who
participate  in  the  market,  management  will  strive  within  the confines of
practical  limitations  to prevent the described patterns form being established
with  respect  to  the  Company's  securities.

NEED  FOR  ADDITIONAL  FINANCING.  The  Company has very limited funds, and such
funds,  may  not  be  adequate  to  take  advantage  of  any  available business
opportunities.  Even  if  the  Company's  currently  available funds prove to be
sufficient to pay for its operations until it is able to acquire an interest in,
or  complete a transaction with, a business opportunity, such funds will clearly
not  be  sufficient to enable it to exploit the opportunity.  Thus, the ultimate
success  of  the  Company  will  depend, in part, upon its availability to raise
additional  capital.  In  the  event that the Company requires modest amounts of
additional  capital  to  fund  its  operations  until  it  is able to complete a
business  acquisition or transaction, such funds, are expected to be provided by
the  principal  shareholders.  However,  the  Company  has  not investigated the
availability,  source,  or  terms  that  might  govern  the  acquisition  of the
additional  capital  which  is  expected  to  be  required in order to exploit a
business  opportunity,  and  will not do so until it has determined the level of
need  for  such  additional  financing.  There  is  no assurance that additional
capital  will  be  available  from  any  source or, if available, that it can be
obtained  on  terms  acceptable to the Company.  If not available, the Company's
operations  will  be  limited  to  those  that  can  be financed with its modest
capital.

NO  OPERATING  HISTORY.   The  Company  has  no operating history, revenues from
operations  or  assets. The Company faces all of the risks of a new business and
the  special risks inherent in the investigation, acquisition, or involvement in
a  new  business opportunity.  The Company must be regarded as a new or start-up
venture  with  all of the unforeseen costs, expenses, problems, and difficulties
to  which  such  ventures  are  subject.

NO  ASSURANCE  OF  SUCCESS  OR  PROFITABILITY.  There  is  no assurance that the
Company  will  acquire  a  favorable  business opportunity.  Even if the Company
should  become involved in a business opportunity, there is no assurance that it
will  generate  revenues  or  profits, or that the market price of the Company's
outstanding  shares  will  be  increased  thereby.

POSSIBLE  BUSINESS  NOT  IDENTIFIED  AND  HIGHLY  RISKY.  The  Company  has  not
identified  and  has no commitments to enter into or acquire a specific business
opportunity.  As  a  result,  it  is  only  able  to  make  general  disclosures
concerning  the  risks  and  hazards of acquiring a business opportunity, rather
than  providing  disclosure  with respect to specific risks and hazards relating


<PAGE>
to  a  particular  business  opportunity.  As  a  general  matter,  prospective
investors  can  expect  any  potential  business  opportunity to be quite risky.

TYPE  OF BUSINESS ACQUIRED.  The type of business to be acquired may be one that
desires  to avoid effecting its own public offering an the accompanying expense,
delays,  uncertainties,  and  federal  and  state  requirements which purport to
protect  investors.  Because of the Company's limited capital, it is more likely
than  not  that  any acquisition by the Company will involve other parties whose
primary  interest  is  the  acquisition of control of a publicly traded Company.
Moreover,  any  business  opportunity  acquired may be currently unprofitable or
present  other  negative  factors.

IMPRACTICABILITY  OF  EXHAUSTIVE INVESTIGATION.  The Company's limited funds and
lack  of  full-time  management will make it impracticable to conduct a complete
and  exhaustive  investigation and analysis of a business opportunity before the
Company  commits  its capital or other resources thereto.  Management decisions,
therefore, will likely be made without detailed feasibility studies, independent
analysis,  market  surveys  and  the  like  which, if the Company had more funds
available to it, would be desirable.  The Company will be particularly dependent
in  making  decisions upon information provided by the promoter, owner, sponsor,
or  others  associated  with  the  business  opportunity  seeking  the Company's
participation.  A  significant  portion  of the Company's available funds may be
expended  for  investigative  expenses and other expenses related to preliminary
aspects  of  completing  an acquisition transaction, whether or not any business
opportunity  investigated  is  eventually  acquired.

LACK  OF  DIVERSIFICATION.  Because  of the limited financial resources that the
Company  has,  it  is  unlikely  that  the Company will be able to diversify its
acquisitions  or  operations.  The Company's probable inability to diversify its
activities  into  more  than  one  area  will  subject  the  Company to economic
fluctuations within a particular business or industry and therefore increase the
risks  associated  with  the  Company's  operations.

NEED  FOR  AUDITED  FINANCIAL  STATEMENTS.  The  Company  will  require  audited
financial  statements  from any business that it proposes to acquire.  Since the
Company  will  be subject to the reporting provisions of the Securities Exchange
Act  of  1934,  as  amended  (the  Exchange Act), it will be required to include
audited financial statements in its periodical reports for any existing business
it  may  acquire.  In  addition,  the lack of audited financial statements would
prevent  the  securities  of  the  Company from becoming eligible for listing on
NASDAQ,  the  automated  quotation  system  sponsored  by  the  Association  of
Securities Dealers, Inc., or on any existing stock exchange.  Moreover, the lack
of  such  financial  statements  is  likely  to  discourage  broker-dealers from
becoming  or  continuing  to  serve  as  market  makers in the securities of the
Company.  Finally,  without  audited  financial  statements,  the  Company would
almost  certainly  be  unable to offer securities under a registration statement
pursuant  to the Securities Act of 1933, and the ability of the Company to raise
capital  would  be  significantly limited.  Consequently, acquisitions prospects
that  do not have, or are unable to provide reasonable assurances that they will
be  able  to  obtain, the required audited statements would not be considered by
the  Company  to  be  appropriate  for  acquisition.

OTHER  REGULATION.  An acquisition made by the Company may be of a business that
is  subject  to regulation or licensing by federal, state, or local authorities.
Compliance  with  such  regulations  and  licensing  can  be  expected  to  be a
time-consuming,  expensive  process and may limit other investment opportunities
of  the  Company.

DEPENDENCE  UPON  MANAGEMENT;  LIMITED PARTICIPATION OF MANAGEMENT.  The Company
will  be entirely dependant upon the experience of its officers and directors in
seeking,  investigating,  and  acquiring  a  business  and  in  making decisions
regarding the Company's operations.  It is possible that, from time to time, the
inability  of  such  persons  to devote their full time attention to the Because
investors  will  not  be able to evaluate the merits of possible future business
acquisitions  by  the  Company,  they  should  critically assess the information
concerning  the  Company's  officers  and  directors.

LACK  OF  CONTINUITY  IN  MANAGEMENT.  The  Company  does not have an employment
agreement  with  any  of its officers or directors, and as a result, there is no
assurance  that  they  will  continue  to  manage the Company in the future.  In
connection  with acquisition of a business opportunity, it is likely the current
officers  and directors of the Company may resign.  A decision to resign will be
based  upon  the  identity  of  the  business  opportunity and the nature of the
transaction,  and  is  likely  to  occur  without  the  vote  or  consent of the
stockholders  of  the  Company.


<PAGE>
INDEMNIFICATION OF OFFICERS AND DIRECTORS. The Company's By-Laws provide for the
indemnification  of  its,  directors,  officers,  employees,  and  agents, under
certain  circumstances,  against  attorney's fees and other expenses incurred by
them  in  any  litigation  to  which  they  become  a  party  arising from their
association  with  or activities on behalf of the Company. The Company will also
bear  the  expenses  of  such  litigation  for  any  of its directors, officers,
employees, or agents, upon such persons promise to repay the Company therefor if
it is ultimately determined that any such person shall not have been entitled to
indemnification.  This  indemnification  policy  could  result  in  substantial
expenditures  by  the  Company,  which  it  may  be  unable  to  recoup.

DEPENDENCE  UPON OUTSIDE ADVISORS.  To supplement the business experience of its
officers  and  directors,  the  Company  may  be required to employ accountants,
technical experts, appraisers, attorneys, or other consultants or advisors.  The
selection  of any such advisors will, be made by the Company's officers, without
any input by shareholders.  Furthermore, it is anticipated that such persons may
be  engaged  on  an  as  needed  basis  without  a continuing fiduciary or other
obligation to the Company.  In the event the officers of the Company consider it
necessary  to  hire  outside  advisors,  they  may elect to hire persons who are
affiliates,  if  those  affiliates  are  able  to provide the required services.

LEVERAGED  TRANSACTIONS.  There  is  a  possibility  that  any  acquisition of a
business  opportunity  by  the  Company  may  be leveraged, i.e. the Company may
finance  the  acquisition  of  the business opportunity by borrowing against the
assets  of  the  business  opportunity  to be acquired, or against the projected
future revenues or profits of the business opportunity.  This could increase the
Company's  exposure to larger losses.  A business opportunity acquired through a
leveraged  transaction  is  profitable  only  if it generates enough revenues to
cover  the  related  debt  and  expenses.  Failure  to make payments on the debt
incurred  to  purchase  the  business  opportunity could result in the loss of a
portion  or all of the assets acquired.  There is no assurance that any business
opportunity  acquired  through  a leveraged transaction will generate sufficient
revenues  to  cover  the  related  debt  and  expenses.

COMPETITION.  The  search  for  potentially profitable business opportunities is
intensely  competitive.  The  Company  expects  to  be  at  a  disadvantage when
competing  with  many  firms  that  have  substantially  greater  financial  and
management  resources  and  capabilities  than  the  Company.  These competitive
conditions  will  exist  in  any  industry  in  which  the  Company  may  become
interested.

NO  FORESEEABLE  DIVIDENDS.  The  Company  has  not paid dividends on its Common
Stock  and  does not anticipate paying such dividends in the foreseeable future.

LOSS  OF  CONTROL  BY  PRESENT  MANAGEMENT AND STOCKHOLDERS. In conjunction with
completion  of  a  business acquisition, it is anticipated that the Company will
issue  an  amount  of  the  Company's  authorized but unissued Common Stock that
represents  the  greater majority of the voting power and equity of the Company.
In  conjunction  with  such  a  transaction,  the  Company's  current  Officers,
Directors,  and  principal  shareholders  could  also sell all, or a portion, of
their  controlling block of stock to the acquired Company's stockholders. Such a
transaction  would  result  in  a greatly reduced percentage of ownership of the
Company  by  its  current  shareholders.  As  a  result,  the acquired Company's
stockholders would control the Company, and it is likely that they would replace
the  Company's  management  with  persons  who  are  unknown  at  this  time.

NO  PUBLIC MARKET EXISTS.  There is currently no public market for the Company's
common stock, and no assurance can be given that a market will develop or that a
shareholder  will  ever be able to liquidate his investment without considerable
delay, if at all.  If a market should develop, the price may be highly volatile.
Factors  such  as  those  discussed  in  this  Risk  Factors  section may have a
significant  impact  upon  the  market  price  of the securities offered hereby.
Owing  to  the  low  price  of  the  securities, many brokerage firms may not be
willing  to effect transactions in the securities.  Even if a purchasers finds a
broker  willing to effect a transaction in theses securities, the combination of
brokerage commissions, state transfer taxes, if any, and any other selling costs
may  exceed  the  selling  price.  Further,  many  leading institutions will not
permit  the  use  of  such  securities  as  collateral  for  any  loans.

BLUE  SKY  CONSIDERATION.  Because  the securities registered hereunder have not
been  registered for resale under the Blue Sky laws of any state, the holders of
such  shares  and persons who desire to purchase them in any trading market that
might  develop  in  the  future,  should be aware, that there may be significant
state  Blue  Sky  law  restrictions  upon  the  ability of investors to sell the
securities  and of purchasers to purchase the securities. Accordingly, investors
should  consider  the  secondary  market  for  the  Company's securities to be a
limited  one.


<PAGE>
ITEM  2.     DESCRIPTION  OF  PROPERTY.

Our  principal  business  address was 1518 West Hastings St., Vancouver, British
Columbia,  Canada.  During  the  fiscal  year ending March 31, 2007, office rent
totaled  $6,000.  The  office  rent  has  been  and will be treated as a capital
administrative  expense.  The  Company  moved  is principal corporate offices to
1111-207  West Hastings St. Vancouver, British Columbia, Canada. No formal rent,
lease  or  sublease has been set up yet and no funds have been paid out for rent
to  date.

ITEM  3.     LEGAL  PROCEEDINGS.

The  Company  is  not  a  party  to  any  pending  legal  proceeding.

ITEM  4.     SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS.

No  matter  was  submitted  to  a  vote  of  the  security  holders, through the
solicitation  of  proxies  or otherwise, during the fourth quarter of the fiscal
year  covered  by  this  report.

                                     PART II

ITEM  5.     MARKET  FOR  COMMON  EQUITY, RELATED STOCKHOLDER MATTERS AND SMALL
             BUSINESS  ISSUER  PURCHASES  OF  EQUITY  SECURITIES.

(a)     Market  Information.

Our  common  stock trades Over-the-Counter (OTC) on the NASD Electronic Bulletin
Board  under  the  symbol  GIMU.  Table  1  sets  forth  the  high  and low sale
information  for  fiscal  years  2007  and  2006.  These  quotations  reflect
inter-dealer prices, without retail mark-up, mark-down or commission and may not
represent  actual  transactions.

<TABLE>
<CAPTION>
Table 1.

Sale Information

Fiscal Quarter Ended          High                  Low
<S>                           <C>                   <C>
March 31, 2007                0.09                  0.09
December 31, 2006             0.12                  0.12
September 30, 2006            0.17                  0.13
June 30, 2006                 0.13                  0.10

March 31, 2006                0.16                  0.16
December 31, 2005             0.25                  0.17
September 30, 2005            0.28                  0.20
June 30, 2005                 0.35                  0.31
March 31, 2005                0.34                  0.30
</TABLE>

(a)     Holders.

Our  company  has approximately 31 record shareholders of its common stock as of
datelstransMonth3Day31Year2007March 31, 2007 holding 16,195,645 common shares. A
significant number of shares are held in "street name" therefore we believe that
the number of beneficial shareholders exceeds the number of record shareholders.

(b)     Dividends.

There  are  no  restrictions  imposed  on the Company which limit its ability to
declare  or  pay  dividends  on its common stock, except for corporate state law
limitations.  No  cash dividends have been declared or paid to date and none are
expected  to  be  paid  in  the  foreseeable  future.

(c)     Recent  Sales  of  Unregistered  Securities:  None

(d)     Securities Authorized for Issuance under Equity Compensation Plans: None


ITEM  6.     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF FINANCIAL CONDITION AND
             RESULTS  OF  OPERATION  OR  PLAN  OF  OPERATION.


<PAGE>
When  used in this Form 10-KSB and in our future filings with the Securities and
Exchange  Commission,  the  words  or  phrases  will  likely  result, management
expects,  or  we  expect,  will  continue,  is anticipated, estimated or similar
expressions  are  intended  to  identify  forward-looking  statements within the
meaning  of  the  Private Securities Litigation Reform Act of 1995.  Readers are
cautioned  not  to  place undue reliance on any such forward-looking statements,
each  of  which speak only as of the date made.  These statements are subject to
risks  and uncertainties, some of which are described below.  Actual results may
differ  materially  from  historical earnings and those presently anticipated or
projected.  We  have  no  obligation  to  publicly  release  the  result  of any
revisions  that  may  be  made  to  any  forward-looking  statements  to reflect
anticipated events or circumstances occurring after the date of such statements.

A.  OPERATING  RESULTS

The  following  discussion  and  analysis  is  based  on  and  should be read in
conjunction  with the Company's audited financial statements including the notes
thereto  and other financial information appearing elsewhere herein. The audited
financial statements have been prepared using Canadian dollars and are presented
in  accordance  with  accounting  principles  generally  accepted  in  Canada.

U.S.  AND  CANADIAN  GAAP  DIFFERENCES

The Company changed its financial reporting currency to the United States Dollar
from  the  Canadian  Dollar.  The operating statements for the fiscal year ended
March  31,  2006  have  been  retroactively  adjusted  to reflect this change in
reporting  currency.  The  financial statements have been prepared in accordance
with  Canadian GAAP, which conform in all material respects with those of the US
and  are  disclosed in note 2 to the audited financial statements of the Company
for  March  31,  2007  and  2006.

RESULTS  OF  OPERATIONS  -  YEAR  TO  YEAR  COMPARISONS  BETWEEN  2007  AND 2006

For  the  year  ended March 31, 2007 the Company achieved sales revenues of $-0-
compared  with  sales  revenues of $-0- for the period ended March 31, 2007. The
Company's  net  loss  for  the  year was $73,765 in 2007 compared to net loss of
$94,957  in  2006.  Such  reduction  in  the  net  loss  was due primarily to an
increased  focus  on reducing expenses. As of the year ended March 31, 2007, the
Company  had  an  accumulated  stockholders'  deficiency  of  $(506,933).

B.  LIQUIDITY  AND  CAPITAL  RESOURCES

YEAR  ENDED  MARCH  31,  2007  COMPARED  WITH  THE  YEAR  ENDED  MARCH  31, 2006

The  Company's  total  assets  decreased  from  $142  in  2006  to $-0- in 2007.

The Company's overall liabilities decreased from $521,046 in 2006 to $506,933 in
2007.

The  Company  has had no significant operations during the last fiscal year and,
accordingly,  is  fully  dependent either future sales of securities or upon its
current  management  and,  or advances or loans from significant stockholders or
corporate  officers  to  provide  sufficient  working  capital  to  preserve the
integrity  of  the  corporate  entity.

There is no assurance that the Company will be able to obtain additional funding
through  the sales of additional securities or, that such funding, if available,
will  be  obtained on terms favorable to or affordable by the Company. It is the
intent  of management and significant stockholders to provide sufficient working
capital necessary to support and preserve the integrity of the corporate entity.
However,  there  is  no  legal  obligation  for either management or significant
stockholders  to  provide  additional  future  funding.

We  will  need  to  raise  capital  in  order  to commence our proposed business
operations.  No  assurance can be given that we will be able to raise sufficient
capital  to  implement any proposed business operations.  We have not identified
any specific future financing sources. In the future, our efforts to finance the
Company  may  result  in  the  issuance of equity and debt instruments. This and
other  future  financing  activity,  if  any,  may  result  in  the  dilution of
shareholder  equity.  We  expect  to  incur financial losses for the foreseeable
future.


<PAGE>
The  Company  has  no residual capital commitment in respect to its discontinued
operations  and  has  no  current  capital  commitments.

US  GAAP  VERSUS  CANADIAN  GAAP

Under  Canadian  GAAP applicable to junior mining exploration companies, mineral
exploration  expenditures  on  prospective properties may be deferred until such
time  as  it  is  determined that further exploration is not warranted, at which
time  the  property  costs  are  written-off.  Under  US  GAAP,  all exploration
expenditures  must  be  expensed  until  an  independent  feasibility  study has
determined  that  the  property  is  capable  of economic commercial production.

There  were  no  property  costs incurred or written off during the 2006 or 2005
fiscal  year  and  accordingly  the  differences  between  the  allowable US and
Canadian GAAP treatments of property costs would result in no change in net loss
under  U.S.  GAAP  from  that  reported  under  Canadian  GAAP.

OFF-BALANCE  SHEET  ARRANGEMENTS:  None

QUANTITATIVE  AND  QUALITATIVE  DISCLOSURES  ABOUT  MARKET  RISK:

The  Company  does  not  issue  or  invest  in  financial  instruments  or their
derivatives  for trading or speculative purposes.  The limited operations of the
Company  are conducted primarily in the Canada, and, are not subject to material
foreign  currency  exchange risk.  Although the Company has outstanding debt and
related  interest  expense,  market risk of interest rate exposure in the United
States  is  currently  not  material.

ITEM  7.     FINANCIAL  STATEMENTS.

The audited financial statements for the Company for March 31, 2007 and 2006 are
attached  hereto  and  form  a  material  part  of  this  Annual  Report.

ITEM  8.     CHANGES  IN  AND  DISAGREEMENTS  WITH ACCOUNTANTS ON ACCOUNTING AND
             FINANCIAL  DISCLOSURE.

On  May  10, 2007, we dismissed or former independent certified accountant James
Stafford  Chartered Accountants and engaged a replacement independent registered
accountant firm named Jorgensen & Co, Certified Public Accountants, of Bellevue,
Washington  ("Jorgensen"),  as  the  Company's new registered independent public
accounting  firm  to audit the Company's financial statements for the year ended
March  31,  2007.

On July 19, 2006, our former independent certifying accountant, Smythe Ratcliff,
LLP,  resigned.  On  July  19,  2006,  we  engaged  James  Stafford  Chartered
Accountants  to  replace  Smythe  Ratcliffe,  LLP.

The  financial  statements reported on by Smythe Ratcliffe, LLP were not subject
to  an  adverse  or  qualified  opinion, or a disclaimer of opinion and were not
modified as to uncertainty, audit scope or accounting principles during the past
two  fiscal  years,  and  interim  periods,  with  the  exception  that  Smythe
Ratcliffe,  LLP  did  issue a going concern opinion which appeared Note 2 of the
Companys  financial  statements  which was a part of the Form 20-F Annual Report
for  the  period  ending  March  31,  2005.

ITEM  8A.     CONTROLS  AND  PROCEDURES.

(a)     Evaluation  of  Disclosure  Controls  and  Procedures.

As  of  the  end  of  the  reporting  period,  March 31, 2007, we carried out an
evaluation,  under the supervision and with the participation of our management,
including  the  Company's  Chairman  and  Chief  Executive  Officer/Principal
Accounting  Officer,  of  the  effectiveness  of the design and operation of our
disclosure  controls and procedures pursuant to Rule 13a-15(e) of the Securities
Exchange  Act  of  1934  (the  "Exchange Act"),  which disclosure  controls  and
procedures  are  designed  to insure that  information required to be  disclosed
by  a company in the  reports  that it files under the Exchange Act is recorded,
processed,  summarized  and reported  within  required time periods specified by
the  SEC's  rules  and  forms.

Based  upon  that  evaluation,  the  Chairman  and the Chief  Financial  Officer
concluded  that  our  disclosure  controls  and  procedures  were  effective  in
timely  alerting  them  to  material  information  relating  to  the  Company
required  to  be  included  in  the  Company's  period  SEC


<PAGE>
filings.  However,  the  material information was untimely filed due to shortage
of  funds  required  to  pay  accountants,  lawyers  and  edgar  filing  agents.

We  were late filing our annual report on Form 10-KSB for the fiscal year ending
March  31, 2007 and our quarterly reports on Forms 10-QSB for the periods ending
June  30,  2006  and  September 30, 2006.  We were late reporting on two Current
Reports on Forms 8-K reporting the events of July 19 and September 15, 2006. The
2006 Annual and Quarterly Reports were late due to a lack of sufficient funds to
pay  the  independent  certifying accountant and retain legal counsel and delays
associated  with  a  change  in  our status from a foreign reporting issuer to a
domestic  U.S.  registrant.

(b)     Changes  in  Internal  Control.

Subsequent  to the date of such evaluation as described in subparagraph(a)above,
there  were  no  changes  in  our  internal controls or other factors that could
significantly affect these controls, including any corrective action with regard
to  significant  deficiencies  and  material  weaknesses.

(c)     Limitations.

Our  management,  including  our  Principal  Executive  Officer  and  Principal
Financial  Officer,  does  not  expect  that our disclosure controls or internal
controls  over  financial  reporting will prevent all errors or all instances of
fraud.  However,  we  believe  that  our  disclosure controls and procedures are
designed to provide reasonable assurance of achieving this objective.  A control
system,  no  matter how well designed and operated, can provide only reasonable,
not  absolute,  assurance  that  the  control  system's  objectives will be met.
Further,  the  design  of  a control system must reflect the fact that there are
resource  constraints,  and the benefits of controls must be considered relative
to  their  costs. Because of the inherent limitations in all control systems, no
evaluation  of  controls  can provide absolute assurance that all control issues
and  instances  of  fraud,  if any, within our company have been detected. These
inherent limitations include the realities that judgments in decision-making can
be  faulty,  and  that  breakdowns can occur because of simple error or mistake.
Controls  can  also  be  circumvented by the individual acts of some persons, by
collusion  of two or more people, or by management override of the controls. The
design of any system of controls is based in part upon certain assumptions about
the likelihood of future events, and any design may not succeed in achieving its
stated  goals  under  all  potential  future conditions. Over time, controls may
become  inadequate  because  of  changes  in  conditions or deterioration in the
degree  of  compliance  with  policies  or  procedures.  Because of the inherent
limitation  of  a  cost-effective  control system, misstatements due to error or
fraud  may  occur  and  not  be  detected.

ITEM 8B.     OTHER INFORMATION:

     ON  MARCH  5,  2007, THE COMPANY CANCELLED 100,000,000 COMMON SHARES IN THE
NAME  OF  Garth  Jensen  Trustee  for  the  Taurus  Trust, 186 Steel St.,Barrie,
Ontario,  Canada.  The shares were issued in trust for a proposed acquisition of
the  rights  to  the  drug  Trioxolane.  Under the terms of the transaction, the
Company  issued  100,000,000  common  shares in trust, which were held in escrow
subject  to the completion of the acquisition. The transaction was not completed
and  the  common  shares  were  returned  to  the  corporate  treasury.


                                    PART III

ITEM  9.     DIRECTORS,  EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
             COMPLIANCE  WITH  SECTION  16(A)  OF  THE  EXCHANGE  ACT.

The  following  table sets  forth the  officers  and  directors  of the  Global
Immune Technologies, Inc.

(a)     Directors and Executive Officers

The following table sets forth the name, age, and position of each Director and
Executive Officer of Global Immune Technologies Inc:


<PAGE>
<TABLE>
<CAPTION>
NAME                  AGE               POSITION                 Term of Office
<S>                   <C>       <C>                            <C>
Donald L. Perks       55        President, CFO, Director       8/15/05-Present

Piers VanZiffle       59        Director                       8/30/05 to 9-15-06
</TABLE>

Donald  L.  Perks:  President/Director  -  elected  at  AGM September 17, 2003 -
resigned  May  9,  2005  -  reappointed  August  15,  2005

Piers VanZiffle: Director - Appointed August 30, 2005, resigned September 2006.

The  directors  of  the  Company  are elected by the shareholders at each annual
general  meeting  of  the  Company,  or,  in  the  event  of a vacancy, they are
appointed  by  the  Board  of  Directors then in office, to serve until the next
annual  general meeting of the Company or until their successors are elected and
ratified.  The  Company's  executive  officers  are  appointed  by  the Board of
Directors  and  serve  at  the  discretion  of  the  Board  of  Directors.

There  are  no arrangements or understandings between the directors and officers
of  Global  Immune Technologies, Inc. and any other person pursuant to which any
director  or  officer  was  or  is  to  be selected as a director or officer. In
addition,  there  are  no  agreements  or  understandings  for  the  officers or
directors  to  resign  at  the  request  of  another  person and the above-named
officers  and  directors are not acting on behalf of nor acting at the direction
of  any  other  person.

The  following summary outlines the professional background of the directors and
executive  officers  of  the  Company.

Donald  Perks,  President,  CFO  and  member  of  the  board  of directors is an
independent  businessman  and  is a self-employed Business Consultant. Mr. Perks
founded Canada Pay Phone and was active in the success of that company from 1994
to  2001.  He  has  been actively managing Global Immune Technologies Inc. since
2003.

Piers  VanZiffle,  Director,  is  an  independent  businessman  and  has  been a
self-employed  Business  Consultant  for  the  past  eight  years. Mr. VanZiffle
resigned  his  position  with  the  Company  on  September  15,  2006.

(b)  Identify  Significant  Employees.  None.

(c)  Family  Relationships.  None  known.

(d)  Involvement  in Certain Legal Proceedings. None of the Company's directors,
     officers,  promoters or control persons, if any, during the past five years
     was,  to  the  best  of  the  Company's  knowledge:

1.   A general  partner or executive officer of a business that had a bankruptcy
     petition  filed  by  or  against it either at the time of the bankruptcy or
     within  the  two  years  before  the  bankruptcy;
2.   Convicted  in  a  criminal proceeding or been subject to a pending criminal
     proceeding  (excluding  traffic  violations  and  other  minor  offenses);
3.   Subject  to  any  order,  judgment,  or  decree, not subsequently reversed,
     suspended  or  vacated, of any court of competent jurisdiction, permanently
     or  temporarily enjoining, barring, suspending or otherwise limiting his or
     her  involvement in any type of business, securities or banking activities;
     and
4.   Found by  a  court  of  competent  jurisdiction  (in  a  civil action), the
     Securities  and  Exchange  Commission  or  the  Commodity  Futures  Trading
     Commission  to  have  violated a federal or state securities or commodities
     law,  and  the  judgment  has  not  been  reversed,  suspended  or vacated.

Audit Committee and Financial Expert:

The  Company  has  no audit committee financial expert, as defined under Section
228.401, serving on its audit committee because it has no audit committee and is
not  required  to have an audit committee because it is not a listed security as
defined in Section 240.10A-3.  Accordingly, all material decisions affecting the
Company's audited financial statements, periodic disclosure with the SEC and its
relationship  with  its auditors are addressed by the entire Board of Directors.


<PAGE>
Compliance  with  Section  16(a)  of  the  Securities  Exchange  Act  of  1934

Section  16(a)  of the  Securities  Exchange Act of 1934 requires the  Company's
directors  and  executive  officers,  and  persons  who own more than 10% of the
Company's  Common  Stock,  to  file with the Securities and Exchange  Commission
initial  reports  of  beneficial  ownership and reports of changes in beneficial
ownership  of  Common Stock of the Company. Officers, directors and greater than
10%  shareholders  are  required  by the Securities and Exchange  Commission  to
furnish  the  Company  with copies of all section  16(a) reports they file.  The
company's  sole  officer  and director failed to file a Form 3 during 2006 which
was  due  datelstransMonth4Day10Year2006April  10,  2006  and  a  Form  5  due
datelstransMonth5Day14Year2007May  14,  2007.

CODE  OF  ETHICAL  CONDUCT.

On October 24, 2006, our board of directors adopted our code of ethical conduct
that applies to all of our employees and directors, including our principal
executive officer, principal financial officer, principal accounting officer or
controller, and persons performing similar functions.

We  believe  the  adoption of our Code of Ethical Conduct is consistent with the
requirements  of the Sarbanes-Oxley Act of 2002. This Code of Ethical Conduct is
attached  to  this  report  as  Exhibit  20.

Our  Code  of  Ethical  Conduct  is designed to deter wrongdoing and to promote:

-              Honest  and  ethical  conduct,  including  the  ethical  handling
               of  actual or apparent conflicts of interest between personal and
               professional  relationships;
-              Full, fair,  accurate,  timely  and  understandable  disclosure
               in reports and documents that we file or submit to the Securities
               &  Exchange Commission and in other public communications made by
               us;
-              Compliance  with  applicable  governmental  laws,  rules  and
               regulations,
-              The prompt  internal  reporting  to  an  appropriate  person  or
               persons  indentified  in  the  code  of violations of our Code of
               Ethical  Conduct;  and
-              Accountability  for  adherence  to  the  Code.

ITEM  10.     EXECUTIVE  COMPENSATION.

The following table shows compensation paid to our Executive Officers during the
two  fiscal  periods  ended  March  31,  2007  and  March  31,  2006.

<TABLE>
<CAPTION>
SUMMARY COMPENSATION
-------------------------------------------------------------------------------------------------------
NAME         YEAR   SALARY     BONUS   STOCK    OPTION   NON-EQUITY   NONQUALIFIED   ALL         TOTAL
AND                 ($)        ($)     AWARDS   AWARDS   INCENTIVE    DEFERRED       OTHER       ($)
PRINCIPAL                              ($)      ($)      PLAN         COMPENSATION   COMPENSA-
POSITION                                                 COMPENSA-    EARNINGS       TION
                                                         TION         ($)            ($)
                                                         ($)
-------------------------------------------------------------------------------------------------------
(a)          (b)    (c)        (d)     (e)      (f)      (g)          (h)            (i)         (j)
<S>          <C>    <C>        <C>     <C>      <C>      <C>          <C>            <C>         <C>
-------------------------------------------------------------------------------------------------------
Don Perks,   2007   24,456(1)  -0-     -0-      -0-      -0-          -0-            -0-         24,456
Pres., CEO   2006   24,456(1)  -0-     -0-      -0-      -0-          -0-            -0-         24,456
and
Director
(1)
-------------------------------------------------------------------------------------------------------
</TABLE>

(1) Don  SnPerks'  annual  compensation  was $CDN 30,000  or  US$24,456.

GRANTS  OF  PLAN-BASED  AWARDS

We  made  no  grants  from plans to any executive officer during the fiscal year
ended  March  31,  2007.

OUTSTANDING  EQUITY  AWARDS  AT  FISCAL  YEAR-END

There  were  no outstanding equity awards to any executive officer at the end of
the  fiscal  year  ended  March  31,  2007.


<PAGE>
<TABLE>
<CAPTION>
OPTION EXERCISES AND STOCK VESTED

------------------------------------------------------------------------------
             OPTIONS  AWARDS                       STOCK  AWARDS
------------------------------------------------------------------------------

             NUMBER                 VALUE         NUMBER OF          VALUE
NAME         OF                     REALIZED      SHARES             REALIZED
             SHARES ACQUIRED ON     UPON          ACQUIRED ON        ON
             EXERCISE               EXERCISE      VESTING            VESTING
             (#)                    ($)           (#)                ($)
------------------------------------------------------------------------------
(a)          (b)                    (c)           (d)                (e)
<S>          <C>                    <C>           <C>                <C>
------------------------------------------------------------------------------
Don Perks,   -0-                    -0-           -0-                -0-
Director
------------------------------------------------------------------------------
</TABLE>

DIRECTOR  COMPENSATION

The Company has not established any policy concerning director compensation.  No
directors received any compensation during the fiscal year ended March 31, 2007.

ITEM  11.     SECURITY  OWNERSHIP  OF  CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

Table  1 lists the persons who are known to the Company to be the owners of more
than  five  percent  of  the  Company's equity shares according to the Company's
records as of datelstransMonth3Day31Year2007March 31, 2007. Beneficial Ownership
of  more  than  5%  based  on  16,195,645  common  shares.

Beneficial Ownership of 5%.

(a) The following shareholders own five (5%) percent or more of our common
stock.

<TABLE>
<CAPTION>
Shareholder Name and Address            Number of Shares              Percentage Ownership
                                        Beneficially Owned            Beneficially Owned
                                        Common Shares                 Common Shares
<S>                                     <C>                           <C>
Azimuth Corporation
P.O. Box 3936
Saint Andrews, NB E5B 3S7               1,000,000                     6.2%
Canada

Capital Associates
828 West 7th St.
Vancouver, B.C. V5Z 1C1
Canada                                  2,500,000                     15.4%

J&J Rentals, Inc.
P.O.Box 683
Miramichi, NB E1V 3T7                   1,000,000                     6.2%
</TABLE>


(b)   Security Ownership of Management.  Based on 16,195,645 shares as set forth
in (a) above as of March 31, 2007.


Table 2.

<TABLE>
<CAPTION>
(1)                          (2)                      (3)                 (4)
Title of Class         Name and Address        Amount and Nature   Percent of Class
Common Stock
<S>              <C>                           <C>                 <C>
Donald Perks     1518 West Hastings St.,
                 Vancouver, British Columbia
                 Canada.                              -0-                -0-
</TABLE>


<PAGE>
(c)Changes  in  Control.

The Company anticipates that compensation will be provided by the Company during
the  Company's  next  financial year to Donald Perks in conjunction with certain
management  and administrative services to be provided to the Company.  The form
of  payment  may  be  common  stock  grants.

LONG  TERM  INCENTIVE  PLANS  - AWARDS IN MOST RECENTLY COMPLETED FINANCIAL YEAR
During  its  most  recently completed financial year, and for the two previously
completed  financial  years, the Company has not awarded or instituted any LTIPs
in  favor  of  its  Named  Executive  Officers.

OPTIONS/SAR  GRANTS  DURING  THE  MOST  RECENTLY  COMPLETED  FINANCIAL  YEAR
No individual grants of Options to purchase or acquire securities of the Company
or  any  of  its  subsidiaries  (whether  or  not  in  tandem  with SARs) or any
freestanding  SARs  were  granted  or  were in effect and in favor of any of the
Company's  Named Executive Officers during the Company's most recently completed
financial  year.

AGGREGATE  OPTIONS/SAR  EXERCISES  DURING  THE MOST RECENTLY COMPLETED FINANCIAL
YEAR  AND  FINANCIAL  YEAR-END  OPTION/SAR  VALUE:  None

DEFINED  BENEFIT  PLANS
The  Company  does  not  have, and at no time during its most recently completed
financial  year  had, any defined benefit or actuarial plans in respect of which
any  of  its  Named  Executive  Officers  were  eligible  to  participate.

COMPENSATION  OF  THE  COMPANY'S  DIRECTORS:  None

MANAGEMENT  CONTRACTS:  None

BOARD  PRACTICES

The  Board of Directors meets periodically to set policy and review the progress
of  the  Company  as  well  as  review  and  approve  budgets  and expenditures.

The  Directors  of  the  Company  are elected by the shareholders at each annual
general  meeting  of  the  Company,  or,  in  the  event  of a vacancy, they are
appointed  by  the  Board  of  Directors then in office, to serve until the next
annual  general meeting of the Company or until their successors are elected and
ratified.

The  Company's  executive  officers  are appointed by the Board of Directors and
serve  at  the  discretion  of  the  Board  of  Directors.

ITEM  12.     CERTAIN  RELATIONSHIPS  AND  RELATED  TRANSACTIONS.

(a)     Transactions  with  Management  and  Others.

Mr.  Perks  annual salary has been set as $24,456 (CND$ 30,000). This salary has
been  and  will  continue  to  be treated as contributed services reflected as a
component  of  additional  paid  in  capital.

Corporate  offices were provided by Donald Perks, the Company's sole officer and
director  for  fiscal  years 2006 and 2007.  For fiscal years 2006 and 2007, the
office  rent  was  not  accounted  for  as a payable to Mr. Perks, but rather as
additional  paid  in  capital.

Donald  Perks  paid certain payables on behalf of the Company the net of $13,054
and  $12,835  during  the fiscal years ending March 31, 2007 and March 31, 2006,
respectively,  in  order  to  settle  outstanding  Company  obligations.

Except as otherwise set forth in this report, no member of management, executive
officer, director, nominee for a director or security holder who is known to the
Company  to own of record or beneficially more than five percent of any class of
the  Company's  voting securities, nor any member of the immediate family of any
of  the  foregoing  persons, has had any direct or indirect material interest in
any  transaction  to  which  the  Company  was  or  is  to  be  a  party.

(b)     Certain  Business  Relationships.


<PAGE>
Except  as  set  forth  in  (a) above, and to the knowledge of management, or as
previously  filed  in the Company's periodic reports, no director or nominee for
director  is  or  has  been  related  to  any person who has been a party to any
transaction  with  the  Company.

(c)     Indebtedness  of  Management.

No  member  of  the  Company's management is or has been indebted to the Company
since  the  beginning  of  its  last  fiscal  year.

(d)     Transactions  with  Promoters.  None  known.


ITEM  13.     EXHIBITS

     (a)  Exhibits

     31     Chief Executive Officer-Section 302 Certification pursuant to
            Sarbanes-Oxley Act.
     32     Chief Executive Officer-Section 906 Certification pursuant to
            Sarbanes-Oxley Act.


ITEM  14.     PRINCIPAL  ACCOUNTING  FEES  AND  SERVICES.

The Company paid or accrued the following fees in each of the prior two fiscal
years to its principal accountant.

<TABLE>
<CAPTION>
                              Year End 3-31-06        Year End 3-31-07
<S>                           <C>                     <C>
Audit Fees                    $         10,482        $         10,000
Audit-related Fees
Tax Fees
All other fees
Total Fees                    $         10,482        $         10,000
</TABLE>

The Company has no formal audit committee. However, as defined in Sarbanes-Oxley
Act of 2002,  the  entire  Board of  Directors  is the  Company's  serves as the
company audit committee.

To our knowledge, the Company's  principal  accountant during 2007 did not
engage any other  persons  or  firms  other  than  the  principal  accountant's
full-time, permanent employees.

                                   SIGNATURES

Pursuant  to  the requirements of Section 13 or 15(d) of the Securities Exchange
Act  of  1934,  the  registrant  has duly caused this report to be signed on its
behalf  by  the  undersigned  thereunto  duly  authorized.

July  23,  2007


Global  Immune  Technologies,  Inc.


/s/  Donald  Perks
--------------------------------
By:
Title:  President,  CEO,  CFO


In  accordance  with  the Exchange Act, this report has been signed below by the
following  persons  on behalf of the Registrant and in the capacities and on the
dates  indicated.

July  23,  2007


/s/  Donald  Perks
--------------------------------
Donald  Perks,  CEO,  CFO,  Director


<PAGE>
<TABLE>
<CAPTION>
                        GLOBAL IMMUNE TECHNOLOGIES, INC.
                                 MARCH 31, 2007

                              Financial Statements


                          Index to financial statements


                                                                   Pages
<S>                                                                <C>
Audit Opinion                                                        1

Balance Sheet                                                        2

Statements of Operations                                             3

Statements of Cash Flows                                             4

Statements of Shareholders' Deficit                                  5

Notes to the financial statements                                   6-8
</TABLE>


<PAGE>
               REPORT OF REGISTERED INDEPENDENT PUBLIC ACCOUNTANTS


Shareholders  and  Board  of  Directors
Global  Immune  Technologies,  Inc.

We  have  audited  the accompanying balance sheet of Global Immune Technologies,
Inc., a Wyoming corporation, as of March 31, 2007, and the related statements of
operations,  shareholders'  deficit and cash flows for the two years then ended.
These  financial  statements are the responsibility of the Company's management.
Our  responsibility is to express an opinion on these financial statements based
on  our  audits.

We conducted our audit in accordance with the standards of the Public Accounting
Oversight  Board  (United  States  of America).  Those standards require that we
plan  and  perform  the  audit  to obtain reasonable assurance about whether the
financial  statements  are  free  of  material  misstatement.  An audit includes
examining,  on  a  test basis, evidence supporting the amount and disclosures in
the  financial  statements.  An  audit  also  includes  assessing the accounting
principles  used  and  significant  estimates  made  by  management,  as well as
evaluating  the  overall  financial statement presentation.  We believe that our
audits  provide  a  reasonable  basis  for  our  opinion.

In  our  opinion,  the financial statements referred to above present fairly, in
all  material  respects,  the  financial position of Global Immune Technologies,
Inc.  as of March 31, 2007, and the results of its operations and its cash flows
for  the two years then ended in conformity with accounting principles generally
accepted  in  the  United  States  of  America.

The  accompanying  financial  statements  have  been  prepared assuming that the
Company  will continue as a going concern. As discussed in Note 2, the Company's
significant operating losses and other factors raise substantial doubt about its
ability  to  continue  as  a  going  concern. Management's plans regarding those
matters  also  are described in Note 2.  The financial statements do not include
any  adjustments  that  might  result  from  the  outcome  of  this uncertainty.

Also,  as  further  described in Note 2, during fiscal 2007, the Company changed
its reporting currency to the United States dollar from the Canadian dollar. The
operating  statements  for  the  fiscal  year  ended  March  31,  2006 have been
retroactively  adjusted  to  reflect  this  change  in  the  reporting currency.


JORGENSEN  &  CO.

/s/ Jorgensen & Co.

Bellevue, WA 98004
June 12, 2007


                                        1
<PAGE>
<TABLE>
<CAPTION>
                        GLOBAL IMMUNE TECHNOLOGIES, INC.
                                  Balance Sheet
                          For the year ended 3/31/2007


<S>                                                            <C>
ASSETS                                                         $         -
                                                               ------------
    TOTAL ASSETS                                               $         -
                                                               ============


LIABILITIES AND SHAREHOLDERS' DEFICIT
  Accounts payable                                             $    18,164
  Due to Officer                                                    86,382
  Due to related parties                                           402,387
                                                               ------------
    Total Current Liabilities                                      506,933

  Contingencies and Commitments                                          -
                                                               ------------
     Total Liabilities                                             506,933

SHAREHOLDERS' DEFICIT
  Cumulative foreign currency adjustment                             3,724
  Accumulated Deficit                                           (3,976,183)
  Common stock
  500,000,000 no par common shares authorized;
  16,195,645 shares outstanding                                  3,465,526
                                                               ------------

    Total Shareholder's Deficit                                   (506,933)
                                                               ------------

TOTAL SHAREHOLDERS' DEFICIT AND LIABILITIES                    $         -
                                                               ============
</TABLE>


                 See accompany notes to the financial statements


                                        2
<PAGE>
<TABLE>
<CAPTION>
                        GLOBAL IMMUNE TECHNOLOGIES, INC.
                            Statements of Operations
                   For the years ended March 31, 2007 and 2006


                                             Year ended    Year ended
                                              3/31/07       3/31/06
                                            ------------  ------------
<S>                                         <C>           <C>

REVENUE                                     $         -   $         -


GENERAL AND ADMIN EXPENSES                       73,765        94,957


                                            ------------  ------------
  Total expenses                                 73,765        94,957
                                            ------------  ------------

NET LOSS FOR THE YEAR                       $   (73,765)  $   (94,957)
                                            ============  ============


Basic and diluted loss per share            $    (0.005)  $    (0.006)
                                            ============  ============


Weighted average number of
shares outstanding                           16,195,645    16,195,645
</TABLE>


                 See accompany notes to the financial statements


                                        3
<PAGE>
<TABLE>
<CAPTION>
                              GLOBAL IMMUNE TECHNOLOGIES, INC.
                             Statement of Shareholders' Deficit
                           For the two years ended March 31, 2007


                            COMMON                                 CUMULATIVE
                            SHARES      PAID-IN     ACCUMULATED    TRANSLATION
                          OUTSTANDING   CAPITAL       DEFICIT      ADJUSTMENT      TOTALS
                          -----------  ----------  -------------  -------------  ----------
<S>                       <C>          <C>         <C>            <C>            <C>
MARCH 31, 2005             16,195,645  $3,440,070  $ (3,807,461)  $     (1,790)  $(369,181)

Foreign Exchange                                                        (4,018)     (4,018)

Contribution of services                   25,456                                   25,456

Net loss for year                                       (94,957)                   (94,957)
                          -----------  ----------  -------------  -------------  ----------
MARCH 31, 2006             16,195,645  $3,465,526  $ (3,902,418)  $     (5,808)  $(442,700)
                          -----------  ----------  -------------  -------------  ----------
Foreign Exchange                                                         9,532       9,532

Net loss for year                                       (73,765)                   (73,765)
                          -----------  ----------  -------------  -------------  ----------
MARCH 31, 2007             16,195,645  $3,465,526  $ (3,976,183)  $      3,724   $(506,933)
                          ===========  ==========  =============  =============  ==========
</TABLE>


                See accompany notes to the financial statements


                                        4
<PAGE>
<TABLE>
<CAPTION>
                        GLOBAL IMMUNE TECHNOLOGIES, INC.
                             Statement of Cash Flows


                                              Year Ended    Year Ended
                                               3/31/07       3/31/06
                                             ------------  ------------
<S>                                          <C>           <C>
OPERATING ACTIVITIES
  Net loss for periods                       $   (73,765)  $   (94,957)

Contribution of services                                        25,456
Write off of loan receivable                                    25,456

CHANGES IN CURRENT ACCOUNTS
  Decrease accounts receivable                         -         8,350
  Decrease accounts payables                    (110,671)      (49,488)
                                             ------------  ------------
  CASH USED IN OPERATIONS                       (184,436)      (85,183)

INVESTING ACTIVITIES                                   -             -

FINANCING ACTIVITIES
  Increase in loan receivable                          -       (25,456)
  Increase in due to related parties             135,111        97,811
  Increase due to officer and director            39,651        16,988
                                             ------------  ------------
  CASH FROM FINANCING ACTIVITIES                 174,762        89,343

  Increase (Decrease) in cash during year         (9,674)        4,160
  Foreign currency translation adjustment          9,532        (4,018)
  Cash beginning of year                             142             -
CASH AT END OF YEAR                          $         -   $       142
                                             ============  ============

Interest paid during year                            None          None
Taxes paid during year                               None          None
</TABLE>


                 See accompany notes to the financial statements


                                        5
<PAGE>
GLOBAL IMMUNE TECHNOLOGY, INC.
Notes to the financial statements - March 31, 2007


     NOTE  1.  NATURE  AND  CONTINUANCE  OF  OPERATIONS

     Global  Immune  Technologies  Inc.  (the  "Company")  (formerly, Secureview
     Systems  Inc.)  originally  incorporated  in  1985. During fiscal 2007, the
     Company  changed  its  name  from  Secure  Systems  Inc.  to  Global Immune
     Technology,  Inc. and incorporated in the state of Wyoming. The Company was
     formerly  a  British Columbia corporation. Its business office continues to
     be  located  in  Vancouver,  British  Columbia,  Canada.  The  Company  is
     considered  a  public  shell  with  administrative  expenses being its only
     operations.

     NOTE  2  -  SIGNIFICANT  ACCOUNTING  POLICIES

     The  following  summary  of  significant  accounting  policies  of  the
     Company  is  presented to assist in understanding the financial statements.
     The  financial  statements  and  notes are representations of the Company's
     management, which is responsible for their integrity and objectivity. These
     accounting  policies conform to accounting principles generally accepted in
     the  Unites  States  of  America  and have been consistently applied in the
     preparation  of  the  financial  statements.

     REPORTING  CURRENCY
     Beginning  in  fiscal  2007,  the  Company uses the United States dollar as
     its  reporting  currency.  For  the  fiscal  year ended March 31, 2006, and
     earlier  the  Company's  reporting  currency  was  the Canadian dollar. The
     operating  statements  for the year ended March 31, 2006 have been restated
     to  reflect  the  United  States  dollar  as  the  reporting  currency.

     USE  OF  ESTIMATES
     The  process  of  preparing  financial  statements  in  conformity  with
     accounting  principles  generally  accepted in the United States of America
     requires  the  use  of estimates and assumptions regarding certain types of
     assets,  liabilities,  and revenues and expenses. It is possible that these
     estimates  and  assumptions  may  differ  from  actual  results.

     RECLASSIFICATIONS
     Certain  amounts  from  prior  periods  have  been  reclassified to conform
     to  the current period presentation. This reclassification has not affected
     the  Company's  accumulated  deficit  or  net  losses  presented.

     GOING  CONCERN  AND  BASIS  OF  PRESENTATION
     The  Company's  financial  statements  have  been  prepared  on  a  going
     concern  basis, which, as a general matter, contemplates the realization of
     assets  and  the  settlement  of  liabilities and commitments in the normal
     course  of  business.

     Management  cannot  provide  assurance  that  the  Company  will ultimately
     achieve  profitable  operations  or  become  cash  flow  positive, or raise
     additional  debt  and/or  equity  capital.  Management  believes  that  the
     Company's  capital  resources  should be adequate to continue operating and
     maintaining  its  business  strategy during the fiscal year ending 31 March
     2008.  Prior to March 31, 2007, the Company closed all of its bank accounts
     and  relies  solely  on  its president, who does not work full time for the
     Company,  to  conduct  its  business.  For  fiscal  2007 and into the first
     quarter  of  fiscal  2008,  operations  were  financed  through  borrowing
     arrangements  with  related  parties.

     Management  plans  to  continue  this  financing  approach for fiscal 2008.
     However,  the  Company  may be unable to do so, and may be unable to access
     needed  additional  capital through alternatives for the near future. Also,
     Management  is  currently  seeking  a  merger candidate with operations and
     other sources of equity or debt financing. There is no assurance that these
     activities  will  be  economically  viable.

     The  matters  discussed  above,  together  with  the  Company's  history of
     operating losses, extensive current debt as reflected in the March 31, 2007
     balance  sheet, and other things, raise substantial doubt about the ability
     of  the Company to continue as a going concern. The financial statements do
     not  include  any  adjustments that might result from a negative outcome of
     these  uncertainties.  Such  adjustments,  if  necessary,  may  include  a
     liquidation basis of presentation for any assets, liabilities and equities,
     which  may  reflect substantially lower values than are currently reflected
     in  the  financial  statements.

     CASH  and  cash  equivalents  include  highly  liquid  investments  with
     original  maturities  of  three  months  or  less.


                                        6
<PAGE>
GLOBAL IMMUNE TECHNOLOGY, INC.
Notes to the financial statements - March 31, 2007


     FAIR  VALUE  OF  FINANCIAL  INSTRUMENTS
     The  Company's  financial  instruments  include  accounts  payable  and
     related  party  loans  payable.  All  instruments  are  accounted  for on a
     historical  cost basis, which, due to the short maturity of these financial
     instruments,  approximates  fair  value  at  March  31,  2007.

     DERIVATIVE  FINANCIAL  INSTRUMENTS
     The  Company  has  not,  to  the  date  of  these  financial  statements,
     entered  into  derivative  instruments  to  offset  the  impact  of foreign
     currency  fluctuations.

     INCOME  TAXES
     Future  income  tax  assets  and  liabilities  are  determined  based  on
     temporary  differences  between  the  accounting  and  the tax bases of the
     assets  and liabilities and for loss carry forwards, and are measured using
     the tax rates expected to apply when these differences reverse. A valuation
     allowance is recorded against any future income tax asset if it is not more
     likely  than not that the asset will be realized. For the fiscal year ended
     March  31,  2007,  the  Company's  net  future income tax assets were fully
     offset  by  a  valuation  allowance.

     BASIC  AND  DILUTED  NET  LOSS  PER  SHARE
     Basic  loss  per  share  is  calculated  based  on  the  weighted  average
     number  of  shares outstanding during the period. The treasury stock method
     is  used for determining the dilutive effect of options and warrants issued
     in  calculating diluted earnings per share. Under this method, the dilutive
     effect  on  loss  per  share  is recognized on the use of the proceeds that
     could  be  obtained  upon  the  exercise  of  options, warrants and similar
     instruments.  It assumes that the proceeds would be used to purchase common
     shares  at  the  average  market  price  during  the  year.  For  the years
     presented,  this  calculation  proved  to  be  anti-dilutive.

     FOREIGN  CURRENCY  TRANSLATION
     The  Company's  reporting  currency  is  the United States dollar while its
     functional currency is the Canadian dollar. Monetary assets and liabilities
     denominated  in  Canadian dollars are translated at the rate of exchange in
     effect  at  the  balance  sheet  date.  Non-monetary  assets and equity are
     translated into United States dollars at their applicable historical rates.
     Revenues  and  expenses are translated at the average exchange rate for the
     period  in which the expenses are incurred. The Company had no revenues for
     the  periods reported. Foreign currency gains and losses are accumulated as
     other  comprehensive  income.

     NOTE  3  -  ACCOUNTS  RECEIVABLE

     The  Company  had  no  accounts  receivable for the fiscal year ended March
     31,  2007.

     NOTE  4  -  LOAN  RECEIVABLE

     During  the  year  ended  31  March  2006,  the Company loaned $30,000 cash
     pursuant  to  an  agreement  dated  23  September  2005  to  Global Lottery
     Corporation,  a  Nevada  corporation. The terms of the agreement state that
     the  Company  shall  have  the  option to convert this promissory note into
     shares  of common stock of Global Lottery Corporation on the basis of $0.10
     per  share.  Management believes collection is doubtful and the balance has
     been  offset  by  a  full  valuation  allowance  as  at  31  March  2006.

     NOTE  5  -  ACCOUNTS  PAYABLE  AND  ACCRUED  LIABILITIES

     Accounts  payable  and  accrued  liabilities  are  non-interest  bearing,
     unsecured  and  have  settlement  dates  within  one  year.

     NOTE  6  -  DUE  TO  RELATED  PARTIES

     As  of  March  31,  2007,  the  Company  owed $86,382 to the Company's sole
     officer  and  director;  and  $402,387  to  two  separate  significant
     shareholders.  The  increase  in  the amount due to the related parties was
     principally  for  payments  made  by  them  during  2007 in satisfaction of
     certain  the  Company's  current  payable  accounts. Amounts due to related
     parties  are  non-interest  bearing,  unsecured  and have no fixed terms of
     repayment.


                                        7
<PAGE>
GLOBAL IMMUNE TECHNOLOGY, INC.
Notes to the financial statements - March 31, 2007


     Also,  during  fiscal  2006,  the  Company's  president  contributed  his
     management  fee of $25,456 ($30,000 CDN) due to him. This was accounted for
     as  a  administrative expense for fiscal 2006 with a corresponding increase
     in  paid  in  capital.

     NOTE  7  -  EQUITY

     COMMON  STOCK
     Common  stock  has  no  par  value.  Shareholders  are entitled to one vote
     for each share on matters submitted to a vote to shareholders, and to share
     pro  rata  in  all  dividends  payable  on  common  stock  after payment of
     dividends  on  any  preferred  shares  having  preference  in  payment  of
     dividends.

     During  the  year  ended  31  March  2006,  the  Company  proceeded  with a
     proposed acquisition of the rights to the drug, Trioxolane. Under the terms
     of  the transaction, the Company issued 100,000,000 common shares in trust,
     which  were held in escrow subject to completion of the acquisition. As the
     transaction  was not completed, the common shares were returned to treasury
     and  the  Company  is  in  the  process  of  canceling  the  certificates.

     SHARE  PURCHASE  WARRANTS
     During  the  year  ended  March  31,  2007,  2,500,000  warrants  expired
     without  being  exercised  by  the  holders. These warrants were originally
     issued  in 2004. Each warrant had entitled the holder to purchase one share
     of the Company's common stock for $0.03. There were no warrants to purchase
     common  shares  outstanding  at  March  31,  2007.

     NOTE  8  -  INCOME  TAXES

     On  March  31,  2007,  the  Company had an unused U.S. NOL carry-forward of
     approximately  $74,000  for U.S. income tax purposes, which begin to expire
     in  2027.  In  addition,  at  March 31, 2007, the Company had approximately
     $445,000  (expressed in U.S. dollars) of unused Canadian net operating loss
     carry forward for Canadian income tax purposes, which expire fully by 2016.

     Management  is  unable  to  determine  that it is more likely than not that
     the  Company  will  generate  profitable  operations  to  benefit  from the
     deferred  tax  aspect of its income tax loss carry-forwards for either U.S.
     or  Canadian income tax purposes, and has fully an allowed for the deferred
     tax  asset  so  that  no  value  is  reflected  in the financial statements
     regardless  of  their  time of expiration. The amount of this allowance has
     increased each fiscal year so that no deferred tax asset has been reflected
     in  the  Company's  financial  statements.

     NOTE  9  -  SUPPLEMENTAL  DISCLOSURES  WITH  RESPECT  TO  CASH  FLOWS

     During  fiscal  2006,  the  Company  loaned  out  and  wrote  off  as
     uncollectible  a  $24,456  ($30,000  in  Canadian dollars) loan receivable.
     Also, during fiscal 2007, related parties paid $117,225 directly in payment
     of  certain  trade creditors payables owed by the Company. These reductions
     in  accounts  payable  and  corresponding  increases in payables to related
     parties  are  reflected  in  the  statement  of  cash flows as reduction of
     accounts  payable  and  an  increase  in  related  party  debt.

     NOTE  10  -  COMMITMENTS  AND  CONTINGENCIES

     The  Company  has  agreed  to  pay  its  president  and  sole  director  a
     management  fee  of  approximately  $2,250  ($2,500  CDN)  per  month.

     During  fiscal  2007,  the  Company  a  proposed  merger agreement with and
     among  MeiPri  Limited,  Primedical  International Ltd and Medical Monitors
     Limited,  was  cancelled.


                                        8